Indication
Vasovagal Syncope
4 clinical trials
5 products
1 drug
Clinical trial
Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV (Post 4)Status: Active (not recruiting), Estimated PCD: 2018-12-20
Product
MidodrineProduct
Matching PlaceboClinical trial
A Randomized, Prospective, Placebo-Controlled, Crossover Study of Atomoxetine in the Prevention of Vasovagal Syncope (POST7)Status: Recruiting, Estimated PCD: 2026-09-01
Product
AtomoxetineDrug
VarlilumabClinical trial
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging SubjectsStatus: Active (not recruiting), Estimated PCD: 2021-03-01
Product
MetoprololClinical trial
A Proof of Principle Study of Ondansetron for the Prevention of Vasovagal Syncope: The Eleventh Prevention of Syncope Trial (POST11)Status: Recruiting, Estimated PCD: 2025-12-31
Product
Ondansetron